Want to see CPMD full AI Analyst Report?
Cannapharmarx (CPMD) Stock Statistics & Valuation Metrics
Total Valuation
Cannapharmarx has a market cap or net worth of $1.42M. The enterprise value is $22.67T.
- Market Cap
- $1.42M
- Enterprise Value
- $22.67T
Share Statistics
Cannapharmarx has 708,689,900 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 708,689,900
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Cannapharmarx’s return on equity (ROE) is 0.37 and return on invested capital (ROIC) is 35.23%.
- Return on Equity (ROE)
- 0.37
- Return on Assets (ROA)
- -1.59
- Return on Invested Capital (ROIC)
- 35.23%
- Return on Capital Employed (ROCE)
- 0.14
- Revenue Per Employee
- 52.39K
- Profits Per Employee
- -428.13K
- Employee Count
- 26
- Asset Turnover
- 0.19
- Inventory Turnover
- 3.09
Valuation Ratios
The current PE Ratio of Cannapharmarx is -0.12. Cannapharmarx’s PEG ratio is 0.00.
- PE Ratio
- -0.12
- PS Ratio
- 0.83
- PB Ratio
- -0.04
- Price to FCF
- 5.60
- Price to Operating Cash Flow
- 5.28
- PEG Ratio
- 0.00
Income Statement
In the last 12 months, Cannapharmarx had revenue of 1.36M and earned -11.13M in profits. Earnings per share was -0.02.
- Revenue
- 1.36M
- Gross Profit
- -2.08M
- Operating Income
- -3.35M
- Pretax Income
- -11.13M
- Net Income
- -11.13M
- EBITDA
- -3.25M
- Earnings Per Share (EPS)
- -0.02
Cash Flow
In the last 12 months, operating cash flow was 258.74K and capital expenditures -258,742, giving a free cash flow of 253.22K billion.
- Operating Cash Flow
- 258.74K
- Free Cash Flow
- 253.22K
- Free Cash Flow per Share
- 0.00
Dividends & Yields
Cannapharmarx pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 17.87%
- Earnings Yield
- -829.18%
Stock Price Statistics
- Beta
- -0.16
- 52-Week Price Change
- 0.00%
- 50-Day Moving Average
- ―
- 200-Day Moving Average
- ―
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Important Dates
Cannapharmarx upcoming earnings date is May 25, 2027, TBA (Not Confirmed).
- Last Earnings Date
- May 19, 2026
- Next Earnings Date
- May 25, 2027
- Ex-Dividend Date
- ―
Financial Position
Cannapharmarx as a current ratio of 0.04, with Debt / Equity ratio of -68.48%
- Current Ratio
- 0.04
- Quick Ratio
- 0.01
- Debt to Market Cap
- 4.24
- Net Debt to EBITDA
- -6.35
- Interest Coverage Ratio
- -1.37
Taxes
In the past 12 months, Cannapharmarx has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Cannapharmarx EV to EBITDA ratio is -2.83, with an EV/FCF ratio of 87.08.
- EV to Sales
- 12.98
- EV to EBITDA
- -2.83
- EV to Free Cash Flow
- 87.08
- EV to Operating Cash Flow
- 85.22
Balance Sheet
Cannapharmarx has $555.00 in cash and marketable securities with $20.63M in debt, giving a net cash position of -$20.63M billion.
- Cash & Marketable Securities
- $555.00
- Total Debt
- $20.63M
- Net Cash
- -$20.63M
- Net Cash Per Share
- -$0.03
- Tangible Book Value Per Share
- -$0.05
Margins
Gross margin is -88.82%, with operating margin of -170.13%, and net profit margin of -666.19%.
- Gross Margin
- -88.82%
- Operating Margin
- -170.13%
- Pretax Margin
- -666.19%
- Net Profit Margin
- -666.19%
- EBITDA Margin
- -458.20%
- EBIT Margin
- -460.58%
Analyst Forecast
The average price target for Cannapharmarx is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 24.81%
- EPS Growth Forecast
- -98.84%
Scores
- Smart Score
- ―
- AI Score
- 44
